Influence of vehicle on antioxidant activity of quercetin: A liquid crystalline formulation

Latin American Journal of Pharmacy

Volumn 26, Issue 6, 2007, Pages 805-810

  Vicentini, Fabiana T M C ^a   Casagrande, Rúbia ^b   Georgetti, Sandra R ^a   Bentley, M Vitória L B ^a   Fonseca, Maria J V ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Antioxidant; Chemiluminescence; DPPH ; Lipid peroxidation; Liquid crystals; Quercetin

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ALPHA TOCOPHEROL; DRUG VEHICLE; HORSERADISH PEROXIDASE; HYDROGEN PEROXIDE; LUMINOL; QUERCETIN; WATER;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG FORMULATION; DRUG QUALITY; DRUG SCREENING; DRUG STABILITY; IC 50; LIPID PEROXIDATION; LIQUID CRYSTAL; MALE; METHODOLOGY; NONHUMAN; OXIDATIVE STRESS; QUALITY CONTROL; RAT;

EID: 39849105213     PISSN: 03262383     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Fuchs, J. & L. Packer (1991) "Oxidative stress - oxidants and antioxidants", In: H. Sies (Ed.), Academic Press, London, 559-83.
2. Saija, A., A. Tomaino, D. Trombetta, M. Giacchi, A. De Pasquale & F. Bonina (1998) Int. J. Pharm. 175: 85-94.
3. Casagrande, R., S.R. Georgetti, W.A. Verri Jr, D.J. Dorta, A.C. dos Santos & M.J.V. Fonseca (2006) J. Photochem. Photobiol. B: Biol. 84: 21-7.
4. Farkas, E., R. Zelkó, Zs. Németh, J. Pálinká s, S. Marton & I. Rácz (2000) Int. J. Pharm. 193: 239-45.
5. Nesseem, D.I. (2001) J. Pharmaceut. Biomed. 26: 387-99.
6. Makai, M., E. Csányi, Zs. Németh, J. Pálinkás & I. Erós (2003) Int. J. Pharm. 256: 95-107.
7. Müller-Goymann, C.C. (2004) Eur. J. Pharm. Biopharm. 58: 343-56.
8. Marquele, F.D., V.M. Di Mambro, S.R. Georgetti, R. Casagrande, Y.M.L. Valim, M.J.V. Fonseca (2005) J. Pharm. Biom. Anal. 39: 455-62.
9. Pedersen, P.L., J.W. Greenawalt, B. Reynafarje, J. Hullihen, G.L. Deccker, J.W. Soper & E. Bustamante (1978) Meth. Cell Biol. 20: 411-81.
10. Cain, K. & D.N. Skilleter (1987) "Biochemical Toxicology", In: K. Snell, B. Mullock (Eds.), IRL Press, Oxford, 217-54.
11. Krol, W., Z. Czuba, S. Scheller, Z. Paradowski & J. Shani (1994) J. Ethnopharmacol. 41: 121-6.
12. Dinis, T.C.P., V.M.C. Madeira & L.M. Almeida (1994) Arch. Biochem. Biophys. 315: 161-9.
13. Di Mambro, V.M., A.E.C.S. Azzolini , Y.M.L. Valim & M.J.V. Fonseca (2003) Int. J. Pharm. 262: 93-9.
14. Shah, J.C., Y. Sadhale & D.M. Chilukuri (2001) Adv. Drug Deliv. Rev. 47: 229-50.
15. Halliwell, B. & J.M.C. Gutteridge (1990) Meth. Enzymol. 186: 1-85.
16. Pietta, P. (2000) J. Nat. Prod. 63: 1035-42.
17. Moure, A., J.M. Cruz, D. Franco, J.M. Dominguez, J. Sineiro, H. Dominguez, M.J. Núñez & J.C. Parajó (2001) Food Chem. 72: 145-71.
18. Choi, E.J.C., K. Chee & B.H. Lee (2003) Eur. J. of Pharmacol. 482: 281-5.
19. Wills, E.D. (1969) Biochem. J. 113: 325-30.
20. Van Acker, S.A.B.E., D.J. van den Berg, M.N.J.L. Tromp, D.H. Griffioen, W.P. van Bennekom, W.J.F. van der Vijgh & A. Bast (1996) Free Radic. Biol. Med. 20: 331-42.
21. Arora, A., M.G. Nair & G.M. Strasburg (1998) Free Radic. Biol. Med. 24: 1355-63.
22. Van Acker, S.A.B.E., G.P. van Balen, D.J. van den Berg, A. Bast & W.J.F. van der Vijgh (1998) Biochem. Pharmacol. 56: 935-43.
23. Georgetti, S.R., R. Casagrande, V.M. Di Mambro, A.E.C.S. Azzolini & M.J.V. Fonseca (2003) AAPS PharmSci. 5: 1-7.
24. Parejo, I., C. Codina, C. Petrakis & P. Kefalas (2000) J. Pharmacol. Toxicol. 44: 507-12.
25. Vicentini, F.T.M.C., S.R. Georgetti, J.R. Jabor, J.A. Caris, M.V.L.B. Bentley & M.J.V. Fonseca (2007) Lat. Am. J. Pharm. 26: 119-24.